CLINICAL TRIAL APPLICATIONS IN CANADA

Main Article Content

Agnes V Klein
Centre for Evaluation of Radiopharmaceutics and Biopharmaceutics, Biologic and Genetic Therapies Directorate, Health Canada

Anne M Tomalin
CanReg Inc

Keywords

Regulations, clinical trials, Health Canada

Abstract

Clinical trials in Canada in Phases I to III or for a new indication in Phase IV are required to conform to specific regulations that are monitored by Health Canada. These regulations apply to manufacturers and independent researchers. The process involves a Clinical Trials application, required practices that are performed during and after the clinical trial and inspection activities

Abstract 259 | PDF Downloads 430

References

NO REFERENCES

Article Sidebar

PDF
Published
Dec 8, 2018

Article Details

How to Cite
V Klein, A., & M Tomalin, A. (2018). CLINICAL TRIAL APPLICATIONS IN CANADA. Journal of Population Therapeutics and Clinical Pharmacology, 12(3). https://mail.jptcp.com/index.php/jptcp/article/view/105
Issue
Vol. 12 No. 3 (2005)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All articles published in JPTCP  are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

V Klein, A., & M Tomalin, A. (2018). CLINICAL TRIAL APPLICATIONS IN CANADA. Journal of Population Therapeutics and Clinical Pharmacology, 12(3). https://mail.jptcp.com/index.php/jptcp/article/view/105